-+ 0.00%
-+ 0.00%
-+ 0.00%

Agomab Therapeutics NV files Form 3 as Chief Business Officer Paul Henryk van der Horst reports beneficial ownership

Reuters·03/18/2026 20:02:47

Please log in to view news